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Abstract. The PML protein was first identified as part 
of a fusion product with the retinoic acid receptor 
(RARa), resulting from the t(15;17) chromosomal 
translocation associated with acute promyelocytic leu- 
kemia (APL). It has been previously demonstrated that 
PML, which is tightly bound to the nuclear matrix, con- 
centrates in discrete subnuclear compartments that are 
disorganized in APL cells due to the expression of the 
PML-RARa hybrid. Here we report that adenovirus 
infection causes a drastic redistribution of PML from 
spherical nuclear bodies into fibrous structures. The 
product encoded by adenovirus E4-ORF3 is shown to 
be responsible for this reorganization and to colocalize 
with PML into these fibers. In addition, we demon- 
strate that E1A oncoproteins concentrate in the PML 
domains, both in infected and transiently transfected 
cells, and that this association requires the conserved 
amino acid motif (D)LXCXE, common to all viral on- 
coproteins that bind pRB or the related p107 and p130 
proteins. The SV-40 large T antigen, another member 
of this oncoprotein family is also found in close associa- 
tion with the PML nuclear bodies. Taken together, the 
present data indicate that the subnuclear domains con- 
taining PML represent a preferential target for DNA 
tumor viruses, and therefore suggest a more general in- 
volvement of the PML nuclear bodies in oncogenic pro- 
cesses. 
T 
HE eukaryotic nucleus is highly organized into dis- 
crete  domains  which  spatially  separate  different 
biochemical processes. A variety of metabolic activ- 
ities such  as DNA  replication, ribosome assembly, tran- 
scription,  and  pre-mRNA  processing localize to distinct 
subnuclear compartments. The most conspicuous example 
is the nucleolus in which rRNAs are assembled into ribo- 
somal  subunits  (reviewed by Scheer and  Weisenberger, 
1994).  DNA replication sites were also shown to concen- 
trate within  discrete regions containing the proliferating 
cell  nuclear  antigen  (PCNA; 1  Bravo  and  Macdonald- 
Bravo,  1987) as well as DNA  methyltransferase (Leon- 
hardt et al., 1992). In addition, the small nuclear ribonu- 
cleoprotein particles (snRNPs), which are the major sub- 
units of spliceosomes, were similarly found to localize to 
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distinct subnuclear structures corresponding to interchro- 
matin  granules,  perichromatin  fibrils,  and  coiled bodies 
(reviewed in Lamond and Carmo-Fonseca, 1993). 
The  systematic  characterization  of  autoimmune  anti- 
bodies that selectively label individual subcellular domains 
has recently identified a novel type of nuclear structures. 
These structures, defined previously by electron microsco- 
pists as a sub-type of nuclear bodies (reviewed in Bouteille 
et al.,  1974), appear as dense spherical particles, 0.3-0.5 
txm in diameter, that often display a doughnut-like mor- 
phology. To  date,  at  least  four  different proteins  have 
been shown to be components of these nuclear bodies: a 
65-kD protein (Epstein, 1984), NDP55 (Ascoli and Maul, 
1991), SP100 (Szostecki et al.,  1990; Xie et al., 1993), and 
PML (Weis et al.,  1994; Dyck et al.,  1994;  Koken et al., 
1994).  The cDNAs encoding two of these proteins have 
been isolated (SP100 and PML). The amino acid sequence 
of SP100  did  not  reveal  any  significant  homology with 
known proteins, while PML appeared as a new member of 
a growing family of proteins characterized by the presence 
of a  Cys/His-rich  cluster  referred to  as  a  RING  finger 
(Freemont et al., 1991), one or two additional Cys/His-rich 
motifs (B boxes), and a predicted coiled--coil region. No 
apparent  functional  similarity  exists  between  the  seven 
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1992). 
PML was first identified as part of a fusion product with 
the retinoic acid receptor et (RARa),  resulting from the 
t(15;17) chromosomal translocation associated with acute 
promyelocytic leukemia (APL) (de Th6 et al., 1991; Kaki- 
zuka et al., 1991; Pandolfi et al., 1991; Goddard et al., 1991; 
Kastner et al., 1992).  This leukemia is characterized by a 
block in differentiation at the promyelocyte stage and a 
particular sensitivity to retinoic acid (RA)  (Huang et al., 
1988; Castaigne et al.,  1990).  We and others have shown 
that the PML-RARe~ hybrid displays an altered nuclear lo- 
calization when compared to that of its normal PML and 
RARa counterparts (Weis et al.,  1994; Dyck et al.,  1994; 
Koken et al., 1994).  In APL cells, most, if not all of the 
PML nuclear bodies are disorganized into numerous and 
aberrant microstructures containing both PML and PML- 
RARe. Strikingly~ RA treatment induces a drastic reorga- 
nization of the altered PML nuclear bodies back to their 
normal  number  and  morphology,  correlating  with  the 
therapeutic effect of RA in the disease. These data strongly 
suggest that the disruption of the PML subnuclear struc- 
tures may play an important role in APL pathogenesis. 
Adenovirus serotype 2 (Ad2) is a DNA tumor virus that 
infects permissive human cells in a lytic cycle. In addition, 
most adenoviruses have transforming properties in rodent 
cells and some serotypes can induce tumors when injected 
into newborn  hamsters  or rats  (reviewed by Boulanger 
and Blair, 1991; Bayley and Mymryk, 1994).  The minimal 
sequences required for adenovirus transformation encom- 
pass the early region 1A (E1A) and EIB genes. The two 
major E1A  proteins, which  are translated from the  13S 
and the 12S mRNAs, play an essential role in both stimu- 
lating viral gene transcription and inducing extended pro- 
liferation  of rodent  cells  (reviewed by  Aku@irvi,  1993; 
Bayley and Mymryk, 1994). However, the full transformed 
phenotype requires  the  coexpression of EIB.  The  E1A 
gene encodes three regions  that  are  well conserved be- 
tween different serotypes and that correspond to three in- 
dependent functional domains (designated CR1, CR2, and 
CR3;  see  Fig.  8)  (Kimelman  et  al.,  1985;  Moran  and 
Mathews, 1987). The CR3 region, that is required for effi- 
cient  transactivation,  is  not  essential  for transformation 
(Lillie et al., 1987; Schneider et al., 1987).  In contrast, the 
CRt and the CR2 regions together with the extreme NH~ 
terminus are essential for transformation- and cell growth- 
regulating  activities of E1A  (reviewed in Moran,  1993). 
These noncontiguous sequences are critical for the binding 
of cellular proteins such as the retinoblastoma (pRB) gene 
product, the pRB-related p107 and p130 proteins and the 
p300 cellular product (Yee and Branton, 1985; Harlow et 
al.,  1986; Whyte et al., 1988; Ewen et al.,  1991; Eckner et 
al., 1994). 
A  number of different proteins are  likely encoded by 
the adenovirus early region 4 (E4), corresponding to seven 
different translational open reading frames (ORFs) (Vir- 
tanen et al., 1984; Freyer et al., 1984)  (see Fig. 4). Two of 
them, ORF3  and ORF6,  have redundant effects in viral 
lytic infection (Huang and Hearing, 1989; Bridge and Ket- 
ner, 1989). While mutation in either of the two proteins es- 
sentially results in a normal productive infection, a double- 
mutant,  defective in  both  ORF3  and  ORF6  expression, 
grows extremely poorly and shows multiple lesions includ- 
ing defects in viral DNA replication, late viral mRNA ac- 
cumulation and protein synthesis as well as failure in the 
shut-off of host cell protein synthesis (Halbert et al., 1985; 
Weinberg and  Ketner,  1986;  Huang  and  Hearing,  1989; 
Bridge and Ketner, 1989).  Little is known concerning the 
biological  activities  of  the  ORF3  and  ORF6  proteins. 
However,  recent  studies  have  shown  that  they  exhibit 
some features characteristic of RNA splicing factors (Oh- 
man et al., 1993). The ORF3 product functions as an exon 
inclusion factor whereas the ORF6 product preferentially 
favors exon skipping (Nordqvist et al., 1994). 
Viruses require the host cell machinery for their life cy- 
cles, and viral infection provides an amenable model sys- 
tem for the functional study of host cell subnuclear struc- 
tures. Since it was previously shown that a type of nuclear 
structure, the PML nuclear bodies, is disorganized during 
APL pathogenesis, we wished to investigate the effects of 
small DNA tumor virus infection on the integrity of these 
structures. Here we show that adenovirus infection causes 
a dramatic redistribution of PML from doughnut-shaped 
nuclear  bodies  into  fibrous  structures  and  that  the  E4- 
ORF3 protein is both necessary and sufficient for this re- 
distribution. The E1A oncoproteins are found to colocal- 
ize with  PML, both in  the  intact  and  filamentous PML 
structures and the conserved region 2 appears to be critical 
for  this  association.  The  SV-40  large  T  protein  is  also 
shown to accumulate in close proximity to the PML nu- 
clear bodies. These results suggest that the PML subnu- 
clear domains represent specialized nuclear matrix regions 
that are preferential targets for small DNA  tumor virus 
oncoproteins. 
Materials and Methods 
Cell Culture, Adenovirus Infection, 
and Transfection Assays 
HeLa cells  were grown in Dulhecco's modified minimum essential me- 
dium, supplemented with antibiotics,  glutamine and 10%  fetal calf serum 
(GIBCO BRL, Gaithersbirg, MD). Suhconfluent cells were infected with 
adenoviruses subtypes 2 and 5 at a multiplicity  of infection of 20-50 focus 
forming units (f.f.u.) per cell, as previously described (Pombo et al., 1994). 
Transfections were performed by the calcium phosphate precipitation 
method. HeLa cells were grown as monolayers on glass coverslips in 35 
mm Petri dishes containing 1 ml of culture medium and transfected with 
4-5 la.g  of expression vector DNA. 24 h after transfection the medium was 
replaced by fresh culture medium and the cells were further incubated for 
24-48  h.  All  transfections were  independently  repeated  at  least  three 
times. 
Immunofluorescence 
Cells grown on coverslips were washed twice in PBS and fixed and perme- 
abilized  according to one of the following protocols: (a) Triton post-fixa- 
tion. Cells were fixed in 3.7% paraformaldehyde (PFA) in PBS for 10 min 
at room temperature, and then permeabilized with 0.5%  Triton X-100 in 
PBS,  for 20 min at room temperature. (b) Triton pre-fixation:  cells were 
extracted with 0.5%  Triton X-100 in CSK buffer (10 mM Pipes, pH 6.8, 
100 mM NaCI, 300 mM sucrose, 3 mM MgCI2, 2 mM EDTA) containing 
0.1  mM PMSF, for 1-3 min on ice,  and then fixed  in 3.7%  PFA in CSK 
buffer, for 10 rain at room temperature, according to Fey et al. (1986); (c) 
SDS post-fixation:  cells were fixed in 3.7% PFA in PBS for 10 min at room 
temperature, and then permeabilized with 0.2%  SDS in 20 mM Tris-HC1, 
pH 7.5, 2.5 mM EDTA, 30 mM NaCI, for 20 rain at room temperature. 
After fixation and permeabilization, the ceils were rinsed in PBS con- 
taining 0.05 % Tween-20 (PBS-Tw), incubated with primary antibodies for 
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secondary antibodies conjugated with either fluorescein or Texas red (Di- 
anova GmbH, Hamburg, Germany). For double-labeling experiments, in- 
cubation with the primary antibodies was performed sequentially. Finally, 
the samples were mounted in VectaShield (Vector Laboratories, Burlin- 
game, CA). The following primary antibodies were used: anti-PML rabbit 
polyclonal serum (Weis et al., 1994),  anti-PML mAb 5El0 (Stuurman et 
al.,  1992), human patient serum Kr (Weis et al.,  1994), anti-SP100 rabbit 
polyclonal serum (Xie et al., 1993), anti-Sm mAb Y12 (Lerner et al., 1981), 
anti-E1A mAbs M1  and M73 (Harlow et al., 1985), anti-SV-40 LT mAb 
Ab-1 (Oncogene Science, Inc., Mineola, NY), anti-E4-ORF3 protein mAb 
A4-7,  anti-E4-ORF6  protein mAb M45  (Obert  et  al.,  1994),  anti-pRB 
mAb G3-245  (Hu et al., 1991), anti-p300 mAbs RW128 and RW105 (a gift 
from Dr.  R.  Eckner, Dana-Farber Cancer Institute, Boston, MA), and 
anti-hsp70 mAb SPA-810 (StressGen, Victoria, B.C., Canada). 
Visualization  of Replication  Sites 
To visualize the sites of viral DNA replication, cells were infected for 8-10 
h, and then pulse-labeled in vivo with 150 ~M bromodeoxyuridine (BrdU; 
Boehringer Mannheim GmbH, Mannheim, Germany) for 20 min. Detection 
of incorporated BdrU was performed as previously described (Pombo et 
al., 1994). Aphidicolin (5 txg/ml) was present in the culture medium for 14 h 
prior to the in vivo pulse with BrdU in order to inhibit the cellular DNA 
polymerase c~.  Control  experiments demonstrated that  treatment  with 
aphidicolin under these conditions abolishes incorporation of BrdU into 
uninfected cells but does not affect detection of viral replication (Pombo 
et al., 1994). 
Microscopy 
Samples were examined with a Zeiss Axiophot fluorescence microscope. 
Images were  recorded using either  a  Hamamatsu  SIT  camera  and  an 
ARGUS 10 image processor (Hamamatsu Photonics) or the confocal mi- 
croscope. Confocal microscopy was performed with the Zeiss laser scan- 
ning microscope LSM 310,  using excitation wavelengths of 488 nm (for 
fluorescein) and 543 nm (for Texas red). The two channels were recorded 
independently and  pseudocolour images were  generated  and  superim- 
posed. Images were photographed on Kodak TMAX 100 film, or directly 
printed using a  Kodak XLS 8300  Digital Printer.  Immuno-electron mi- 
croscopy was performed on both non-infected and  adenovirus-infected 
HeLa cells as described previously (Weis et al., 1994). 
Plasmid DNA 
Plasmid pE1A contains nucteotides 1 to 1,773 of genomic Ad2 sequences 
(pML 005  in Bondesson et al.,  1994).  Variants of this parental plasmid 
were constructed. The suffixes 12S and 13S denote that genomic EIA se- 
quences were replaced by cDNA sequences taken from the E1A-12S and 
E1A-13S mRNAs (Perricaudet et al.,  1979). ACR1, ACR2a, and ACR2b 
are  in-frame deletion mutants lacking amino acids 38-65,  121-125,  and 
125-133, respectively (Schneider et al., 1987). Variant ACR1,2a  was con- 
structed by combining the deletions in the ACR1  and ACR2a mutants. 
The p12S.A  COOH terminus mutant was derived from pKGO-007 Doff 
(Linder  et  al.,  1991)  and  lacks  the  amino  acids  140-243.  Plasmids 
p12S.YH47,  p12S.pm928,  p12S.YH47/pm928,  and  p12S.RG2  were  kind 
gifts from Elizabeth Moran (Cold Spring Harbor Laboratory, Cold Spring 
Harbor,  NY)  and have been described previously (Wang et al.,  1993). 
CMV expression plasmids encoding E4-ORF3,  ORF6,  ORF6/7  are de- 
scribed in Ohman et al. (1993). The pDept vector expressing the SV-40 LT 
antigen was described in Banerji et al. (1983).  The pCMVRB expression 
vector was a  gift from Kristian Helin  (Danish Cancer Society, Copen- 
hagen). 
Western Blot Analysis 
HeLa cells were infected with mutant virus H5d1366-ORF3  (making E4- 
ORF3; Huang and Hearing, 1989a) or H5ilE41 (making E4-ORF6 and E4- 
ORF6/7; Hemstr0m et al.,  1988) as described by Nordqvist et al. (1994). 
293  cells were transfected with plasmids pUC19, pCMVE4, pCMVE4- 
ORF3, pCMVE4-ORF6, or pE4-ORF3- (Ohman et al., 1993). Cells were 
harvested 28-h postinfection and 48-h posttransfection, lysed by treatment 
with IsoB-0.5% NP-40, and fractionated into nuclei and cytoplasm (Nord- 
qvist et al., 1994). Nuclei were disrupted with Laemmli sample buffer and 
total nuclear proteins separated by electrophoresis in a 15% sodium dode- 
cyl  sulfate-polyacrylamide gel  and  electroblotted onto  a  nitrocellulose 
membrane. Expression of the E4-ORF3 protein was detected using the 
ECL system as described by the manufacturer (Amersham). The mono- 
clonal  antibody A4-7 was  prepared against the E4-ORF3  protein pro- 
duced in  Escherichia  coil  as a  histidine fusion protein (Novagen,  Inc., 
Madison, WI). 
Results 
Adenovirus Infection Causes a Redistribution  of PML 
Immunofluorescence analysis of uninfected HeLa cells us- 
ing an anti-PML serum reveals a variable number of bright 
dots  in  the  nucleus  (Fig.  I  A),  as  previously  described 
(Weis et al., 1994; Dyck et al., 1994; Koken et al., 1994). In 
contrast, at 6-8-h postinfection with adenovirus, the anti- 
PML serum labels a meshwork of fibrous structures in the 
nucleoplasm (Fig. 1 B), which appear to remain unaltered 
up to 24 h after infection. Such fibers were visible in every 
infected cell as checked by double labeling with an anti- 
body directed  against the  adenovirus DNA-binding  pro- 
tein and the PML antiserum (data not shown). Similar re- 
sults  were  obtained  in  MCF-7  cells  infected  with  either 
Figure  1.  Adenovirus  infection redistributes  PML.  Indirect  im- 
munofluorescence  was  performed  using  anti-PML  serum  on 
HeLa cells before (A) and after Ad2 infection (B, 8-h postinfec- 
tion).  The  cells were  fixed with  paraformaldehyde  and  perme- 
abilized with Triton  X-100.  The  distribution of PML was com- 
pared to that of SP100 in the nucleus of non-infected (C and E) 
and infected (D and F) HeLa cells using human autoimmune Kr 
(C and D), and rabbit anti-PML (E and F) sera. Bar, 10 Izm. 
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PML serum or anti-PML monoclonal antibody 5El0 (Figs. 
1 and 4; and data not shown). 
Since the nuclear bodies that contain PML represent a 
macromolecular multiprotein complex (Weis et al., 1994; 
Dyck et al., 1994; Koken et al., 1994), it was important to 
determine whether adenovirus acts exclusively on PML or 
whether it affects the whole complex. Therefore, we per- 
formed immunofluorescence of infecte~d HeLa cells using 
antibodies specific for another component of the PML do- 
mains, the SP100 protein (Szostecki et al., 1990; Xie et al., 
1993).  We  tested  both  polyclonal rabbit  antisera  raised 
Figure 2.  Localization of PML by electron microscopy. A-C depict the nucleus of Ad2 infected cells at 9-h postinfection. The nucleo- 
plasm contains prominent clusters of interchromatin granules (A, arrowheads)  and several viral-induced fibrillar spheres (A and B, 
small arrows). The nucleoli appear compact and predominantly granular (A, n). In addition, nuclear filaments are frequently observed 
(A and B, arrow; the area indicated in A by the large arrow is shown at higher magnification in B). The filaments  form meshworks (B) 
or bundles (C) and are labeled by PML antibodies. For comparison, D depicts a typical doughnut-shaped structure labeled by PML an- 
tibodies in non-infected cells. Bars: (A) 1 I~m ;  (B-D) 0.1 I~m. 
The Journal of Cell  Biology,  Volume 131, 1995  48 Figure 3.  The PML fibrous structures do not correspond to sites of viral DNA replication or RNA processing. (A) HeLa cells were in- 
fected with Ad2 for 8 h incubated for 30 min with bromodeoxyuridine (BrdU) and labeled with PML antibodies. The sites of replication 
were visualized using anti-BrdU antibodies coupled to fluorescein (green staining) and PML was detected with antibodies coupled to 
Texas red (red staining). Confocal images from each fluorochrome were taken separately and superimposed. (B) HeLa cells infected for 
16 h were incubated with mAb Y12, which reacts with common proteins in each of the splicing snRNP (green staining) and PML anti- 
bodies (red staining). Bar, 10 t~m. 
against recombinant SP100  (Szostecki et al., 1990;  Xie et 
al., 1993),  and the Kr human  autoantiserum which recog- 
nizes the same antigen (Weis et al., 1994). Surprisingly, all 
of these antibodies failed to react with the majority of in- 
fected  cells,  contrasting  with  a  bright  staining  of  unin- 
fected cells (Fig. 1 C; and data not shown). However, in a 
small percentage  of infected cells the  SP100  antigen was 
observed  in  association with  the  fibrous  structures  con- 
taining PML (Fig. 1, D  and F). 
To further characterize the viral-induced structures that 
contain PML, we used PML antibodies to perform immu- 
noelectron microscopy. At 9-12 h  after adenovirus infec- 
tion, the PML  antibodies label meshworks  or bundles of 
nuclear  filaments  of ~12  nm  in  diameter  (Fig. 2, A-C). 
This  contrasts  markedly  with  the  larger,  ~0.5-txm-diam 
round  PML-containing  nuclear  bodies  present  in  non- 
infected cells (Fig. 2 D; see also Weis et al., 1994; Koken et 
al., 1994). 
Figure 4.  Mutations in the E4 
gene  abrogate  the  viral- 
induced  redistribution  of 
PML.  (A)  Schematic  repre- 
sentation of proteins (ORFs) 
encoded by the Ad E4 tran- 
scription unit. The position of 
E4-ORF3, which is most rele- 
vant for this study, is shown 
shaded.  (B-E)  HeLa  cells 
were  infected  with  either 
wild-type virus  Ad5  (B)  or 
the  following Ad5  mutants: 
H5dl  1005,  which  deletes 
ORFs 1 and 2 (C); H5d11006, 
which deletes ORFs 1, 2 and 
3 (D); and H5dl 1007, which 
deletes ORFs 3  and also af- 
fects the ORF6 product (E). 
At  12-h  postinfection,  the 
cells were analyzed by immu- 
nofluorescence  using  PML 
antibodies. Bar, 10 I~m. 
Carvalho  et al. Targeting of  Adenovirus E1A and E4-ORF3  49 Figure 5.  The E4-ORF3 gene product colocalizes  with PML in infected cells. (A) Western blot analysis: nuclear extracts from 293 cells 
transfected with the indicated expression plasmids (lanes 1-5, from left), and nuclear extracts from uninfected HeLa cells (lane 6), and 
from HeLa cells infected with H5d1366-ORF3  (encoding E4-ORF3, lane  7) and H5ilE4I (encoding E4-ORF6 and ORF6/7, but not 
ORF3, lane 8) were electrophoresed and immunoblotted with A4-7, a mAb raised against bacterially-produced E4-ORF3 protein. Spe- 
cific E4-ORF3 band is indicated. (B-D) HeLa cells infected for 8 h were fixed with paraformaldehyde, incubated with 0.2%  SDS and 
double-labeled using mAb A4-7 and PML antibodies.  The binding sites of mAb A4-7 were visualized with fluorescein (B) and those of 
PML antibodies with Texas red (C). Confocal images from each fluorochrome were recorded and superimposed (D; green staining for 
the E4-ORF3 protein, red staining for PML). Overlapping of red and green staining produces a yellowish color (arrows).  Note the pres- 
ence of cytoplasmic structures labeled by the mAb A4-7, which are not labeled by PML antibodies (arrowheads).  Bar, 10 ~m. 
We next wished to determine whether the viral-induced 
fibrous structures  containing PML correspond to sites  of 
viral replication,  transcription  or RNA processing.  To vi- 
sualize the sites of viral replication, infected cells were in- 
cubated with BrdU in the presence of aphidicolin in order 
to  specifically  inhibit  the  cellular  DNA  polymerase  c~ 
(Pombo et  al.,  1994).  Double-labeling  experiments  using 
BrdU  and PML antibodies  showed no colocalization be- 
tween the PML fibers and the sites  of replication  (Fig. 3 
A). In addition,  these  experiments  revealed the presence 
of fibrous  structures  stained  by PML antibodies  in  cells 
that did not incorporate BrdU, indicating that these struc- 
tures  form before  the  onset of viral replication.  We  also 
compared  the  staining  pattern  of PML  in  infected  cells 
with the labeling produced by Sm antibodies,  which react 
with  common  proteins  in  each  of  the  splicing  snRNPs 
(Lerner et al., 1981). The labeling pattern of Sm antibodies 
has been previously shown to colocalize with the sites  of 
viral transcription in the nucleus of infected cells and thus 
presumably  represents  the  sites  of  viral  RNA  splicing 
(Jim6nez-Garcia  and  Spector,  1993; Pombo et  al.,  1994). 
Confocal overlays of the separate PML and snRNP label- 
ing patterns  show that  they do not colocalize (Fig.  3  B). 
We  therefore  conclude  that  the  PML  fibrous  structures 
are distinct from sites of viral DNA replication, transcrip- 
tion, and RNA processing. 
The E4-ORF3 Gene Product Is Responsible 
for PML Redistribution 
To identify which viral protein(s)  cause(s)  the redistribu- 
tion of PML, HeLa cells were infected with a variety of ad- 
enovirus mutants and tested for the pattern of PML distri- 
bution. We observed that in cells infected with some types 
of E4 mutants, the normal dot-like distribution of PML re- 
mained  unaltered  (Fig.  4).  Since  the E4  region is  a  very 
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PML. HeLa cells were transiently transfected  with CMV expres- 
sion vectors encoding either E4-ORF3  (A-D), E4-ORF6 (E and 
F) or E4-ORF6/7 (G and H). The cells were analyzed by immu- 
nofluorescence  using antibodies directed against PML (A, C, E, 
and G), E4-ORF3 protein (B), SP100 (D), and E4-ORF6 protein 
(Fand H). Bar, 10 ~m. 
complex transcription  unit  that  encodes  a  minimum  of 
seven proteins (Fig. 4 A) (Freyer et al.,  1984; Virtanen et 
al., 1984), we made use of distinct deletion mutations of E4 
in order to identify the protein(s) required for PML redis- 
tribution. The following E4 mutations were tested (Bridge 
and Ketner, 1989):  (a) H5dl 1005,  which deletes ORFs  1 
and 2; (b) H5dl 1006, which deletes ORFs 1, 2, and 3; and 
(c) H5dl  1007,  which deletes  ORF3  but  also  affects the 
ORF6 product. The results show that, whereas mutant dl 
1005 induces the typical filamentous structures with an ef- 
ficiency similar to that of the wild-type virus (Fig. 4 C), E4 
mutants dl 1006 and dl 1007 fail to alter PML distribution 
(Fig. 4, D  and E). Therefore, the protein encoded by E4- 
ORF3 appears to be responsible for PML redistribution. 
The  intraeellular  localization  of  the  adenovirus  E4- 
ORF3 protein was analyzed using a monoclonal antibody 
(A4-7)  generated  against  the  E4-ORF3  gene  product. 
Western  blot  analysis indicates that  this  antibody reacts 
specifically with the viral 11-kD protein encoded by E4- 
ORF3  both in E4 transfected cells and during lytic virus 
infection  (Fig.  5  A).  Indirect  immunofluorescence  per- 
formed in infected cells revealed that mAb A4-7 stains a 
reticular meshwork in the nucleoplasm (Fig. 5 B) and dou- 
ble-labeling experiments show that both ORF3 and PML 
antibodies label the same fibrous structures (Fig. 5, B-D). 
Finally,  transient  DNA  transfection  experiments  using 
CMV expression vectors encoding single E4-ORFs dem- 
onstrated that expression of ORF3 is sufficient to induce 
the formation of a meshwork of intranuclear filamentous 
structures  labeled  by  antibodies  directed  to  ORF3  and 
PML (Fig. 6, A  and B). Similarly to what we observed in 
infected cells, these structures were stained by the SP100 
antiserum (Fig. 6, C and D). 
In contrast to the effect of E4-ORF3, overexpression of 
E4-ORF6  in  transfected cells does not  alter  the  normal 
PML distribution and, in these cells, an antibody specific 
for the E4-ORF6 protein produces a diffuse staining both 
in the nucleus and in the cytoplasm (Fig. 6, E and F). This 
finding  is  important  since  previous  studies  have  shown 
that the ORF3 and ORF6 products appear to have redun- 
dant activities in supporting lytic virus growth (Huang and 
Hearing,  1989;  Bridge  and  Ketner,  1989).  In  addition, 
transfection of an E4-ORF6/7 expression plasmid does not 
alter  the  normal  PML  distribution  and  the  viral hybrid 
protein  is  detected  diffusely distributed  throughout  the 
nucleoplasm (Fig. 6, G and H). 
The Adenovirus E1A Oncoproteins Colocalize with 
PML in the Nucleus of Virus-infected Cells 
Having established that adenovirus infection causes a re- 
distribution of PML into fibrous structures, we next sought 
to investigate whether the E1A oncoproteins may associ- 
ate  with  these  virus-induced  structures.  We  carried  out 
double-labeling experiments on infected HeLa cells using 
PML serum and monoclonal antibody M73 raised against 
EIA (Harlow et al., 1985). When cells were first fixed with 
paraformaldehyde and then extracted with Triton X-100, 
mAb  M73  produced widespread staining throughout the 
nucleoplasm (Fig. 7/). However, when the cells were ex- 
tracted with Triton X-100 prior to fixation with parafor- 
maldehyde, this diffuse staining was significantly reduced 
and  a  meshwork  of nucleoplasmic fibers became visible 
(Fig. 7 A). Such extraction in situ, while removing the solu- 
ble proteins, leaves the nuclei intact (Mittnacht and Wein- 
berg, 1991; Fey et al., 1986). These fibrous structures were 
labeled by both mAb M73 and the PML serum (Fig. 7, A-C), 
demonstrating that the EIA proteins localize to the PML 
domains in the nucleus of infected cells. 
A  reticular pattern of E1A had been described previ- 
ously in the nuclei of infected cells and shown to colocalize 
with the 70-kD heat shock protein (hsp70) (White et al., 
1988).  To test whether hsp70 may concentrate within the 
virus-induced PML fibers, we double-labeled infected cells 
with the PML serum and anti-hsp70 mAb SPA-810. In a 
small  percentage  of cells,  we  found  a  clear overlay be- 
tween both staining patterns (data not shown), indicating 
that hsp70 colocalizes with E1A in the PML filamentous 
structures. 
Carvalho et al. Targeting  of  Adenovirus E1A and E4-ORF3  51 Figure 7.  The EIA proteins colocalize with PML domains. (A-C) Indirect immunofluorescence was performed on HeLa cells at 14-h 
postinfection using the anti-E1A mAb M73 and PML serum. The cells were extracted with Triton X-100 and then fixed with parafor- 
maldehyde. The binding sites of the mAb M73 were visualized with fluorescein (A) and those of PML antibodies with Texas red (B). (C; 
green staining for the E1A proteins, red staining for PML). Note that the yellow color is produced by overlapping of red and green stain- 
ing). When infected cells were first fixed with paraformaldehyde and then treated with Triton X-100, the M73 antibody produced an in- 
tense diffuse staining of the nucleoplasm and concentration in PML domains was not clearly detected (/).(D-F) HeLa cells were tran- 
siently transfected with plasmid pE1A, which expresses E1A proteins, and double-labeled with M73  (D, visualized using fluorescein) 
and PML serum (E, visualized using Texas red). Images from each fluorochrome were recorded and superimposed (F, green staining for 
E1A proteins, red staining for PML). (G and H) HeLa cells were transiently transfected with plasmid pl2SACR2a, which expresses an 
E1A-12S deletion mutant lacking amino acids 121-125.  These cells were double-labeled  with mAb M73 (G) and PML serum (//). Note 
that this deleted form of E1A does not concentrate in PML domains, even at high levels of E1A expression, as assessed by the intensity 
of the immunofluorescence signal (G). For D-H, that correspond to immunofluorescence performed in transfected cells, similar results 
were obtained when cells were permeabilized either before or after fixation. Bar, 10 tzm. 
The CR2 Region of the E1A Oncoproteins Is Necessary 
for the Association  with the PML Nuclear Bodies 
Having established that both E1A and E4-ORF3 encoded 
proteins colocalize with PML in adenovirus infected cells 
and  that  ORF3  is  responsible  for  the  redistribution  of 
PML from nuclear bodies into nuclear fibrous structures, 
it was important to determine whether the apparent asso- 
ciation between EIA and PML is restricted to these viral- 
induced fibrous structures or whether it can also occur in 
the normal nuclear bodies. To address this question, HeLa 
cells were transiently transfected with vectors expressing 
E1A  proteins  and  analyzed  by  indirect  immunofluores- 
cence  using E1A  and  PML  antibodies. The  results show 
that  the  proteins  expressed  by  transfection  of  the  E1A 
gene are distributed throughout the nucleoplasm with ad- 
ditional concentrations in a  few brighter dots that colocal- 
ize with the PML domains (Fig. 7, D-F). These loci were 
The Journal  of Cell Biology,  Volume 131, 1995  52 Figure 8.  Schematic  representation of the  domain structure  of 
E1A.  Diagram of EIA proteins encoded  by the  13S  and  12S 
mRNAs indicating splice junctions,  conserved regions 1, 2, and 3 
(CR1-3),  including  the  (D)LXCXE motif of CR2,  and regions 
critical  for p300, pRB, p107, and p130 binding  (upward lines). 
The designations  of specific mutations are underlined. 
observed regardless of the method used (i.  e., when cells 
were treated with Triton X-100 either before or after para- 
formaldehyde fixation). 
To test whether the colocalization of EIA proteins with 
PML depends upon the sequences of EIA that are critical 
for efficient transactivation and/or transformation, we an- 
alyzed the intracellular localization of a series of E1A mu- 
tants (see Fig. 8, Table I). HeLa cells were first transfected 
with  plasmids  encoding  either  E1A-13S  (which  contains 
the  CR1,  CR2,  and  CR3  sequences)  or E1A-12S  (which 
only contains the CR1 and CR2 sequences). Both 12S and 
13S proteins were detected diffusely distributed in the nu- 
cleoplasm with additional concentrations in the PML do- 
mains (Table I), indicating that the CR3 region is not re- 
quired for the concentration  of EIA in the PML bodies. 
Colocalization between EIA and PML was also observed 
in cells transfected with E1A mutants harboring deletions 
in either the CR1, the CR2b regions or in the carboxy-ter- 
minal exon (Table I). In contrast, E1A deletion mutants 
lacking both CR1  and CR2a regions or the  CR2a region 
alone failed to concentrate in the PML domains (Fig. 7, G 
and H). This indicates that the (D)LXCXE motif which is 
disrupted in the ACR2a mutant (Fig. 8) appears critical for 
the concentration of EIA protein in the PML structures. 
Since the integrity of this motif is required for the high 
affinity association of E1A to the pRB product and its re- 
lated proteins p107  and p130  (reviewed by Moran,  1993; 
Bayley and Mymryk, 1994), we were interested in extend- 
ing our analysis to other EIA mutants defective in binding 
these  proteins.  Cells were  transfected with the  following 
EIA  point  mutants:  12S.pm928  which  abrogates  pRB 
binding selectively, 12S.YH47 which abrogates both pRB 
and p130 binding, and the double point mutant 12S.YH47/ 
pm928 which disrupts binding of pRB, p107, and p130 pro- 
teins (Wang et al., 1993). None of these mutations affected 
the normal colocalization of E1A with PML (Table I). We 
therefore conclude  that  the  sequences  required  for E1A 
concentration in PML domains overlap but are not identi- 
cal to those involved in the interaction of EIA with pRB 
Table L Transfections  with E1A and E1A Mutant DNAs and 
Co-immunolocalization  with PML Protein 
E1A Construct  E1A in PML Nuclear Bodies 
)E1A  + 
)13S  + 
~12S  + 
~12S.DCR1  + 
12S.DCR1,2a 
12S.DCR2a 
~12S.DCR2b  + 
12S.DC-term*  + 
p 12S.pm 928  + 
p 12S.YH47  + 
p 12S.YH47/pm928  + 
pl2S.RG2  + 
* E 1A product detected with mAb M 1; all others detected with mAb M73 (Harlow et 
al., 1985). 
products. This is consistent with the finding that anti-pRB 
antibodies produce a  diffuse staining of the  nucleoplasm 
without any clear concentration in PML domains, both in 
uninfected  and  in  adenovirus-infected cells, as well as in 
cells transfected with an pRB expression vector (data not 
shown). 
In addition to the CR1 and CR2 regions, the NH~ termi- 
nus of E1A products is also strictly required for EIA plus 
ras transformation and this function is believed to involve 
binding of another cellular protein, p300 (Subramanian et 
al., 1988; Whyte et al., 1989; Wang et al., 1993).  In order to 
test whether this sequence is important for the colocaliza- 
tion of EIA with PML, HeLa cells were transiently trans- 
fected with the EIA point mutant  12S.RG2  which selec- 
tively abrogates p300 binding (Wang et al., 1993).  Indirect 
immunofluorescence  revealed that  this  E1A  product  re- 
tains the  ability to concentrate  within the  PML domains 
(Table I). In this  regard,  antibodies  directed  against the 
nuclear p300 protein (Eckner et al., 1994)  did not reveal 
any specific labeling of the PML domains but rather exhib- 
ited a homogeneous nuclear staining that excluded the nu- 
cleoli (data not shown). 
The SV-40 Large T Antigen Accumulates in Close 
Proximity to PML Nuclear Bodies 
As the (D)LXCXE motif present in the conserved region 
2 of EIA appears to be required for the concentration of 
EIA proteins in the PML nuclear bodies, we decided  to 
examine whether other viral gene products which contain 
similar amino acid motifs can also interact with these do- 
mains.  To  address  this  question,  cells  were  transiently 
transfected with a  vector expressing the early SV-40 pro- 
teins (Banerji et al.,  1983)  and  analyzed by immunofluo- 
rescence using an antibody specific to the Large T antigen 
(LT). The results show that LT is distributed throughout 
the nucleoplasm and, in addition, concentrates in discrete 
loci  (Fig.  9 A).  These loci are particularly evident when 
the  cells are mildly extracted with Triton X-100 prior to 
formaldehyde fixation. Double-labeling experiments using 
LT and PML antibodies reveal that the sites of LT concen- 
tration  are  frequently  associated  with  the  PML  nuclear 
bodies (Fig. 9, A-C). In a total of 20 transfected cells, we 
observed that 83% of the loci labeled by LT antibody are 
Carvalho et al. Targeting of  Adenovirus  EIA and E4-ORF3  53 Figure 9.  SV-40 large T antigen  associates with the PML domains. HeLa cells were transiently  transfected with plasmid pDept which 
encodes early SV-40 proteins (Banerji et al., 1983). The cells were permeabilized with Triton X-100 and then fixed with paraformalde- 
hyde. The large T antigen (LT) was detected using mAb Ab-1 and visualized with fluorescein (A). PML was visualized using rabbit an- 
tiserum and Texas Red (B). C represents the superimposition  of confocal images obtained from each fluorochrome (green staining for 
LT, red staining for PML). Note that the structures  labeled by antibodies directed against LT and PML are closely associated but do not 
colocalize precisely (arrows). Bar, 10 Ixm. 
in close proximity to PML nuclear bodies. These results in- 
dicate  that,  in  transfected cells, in  addition  to being dif- 
fusely  distributed  in  the  nucleoplasm,  LT  concentrates 
within distinct  subnuclear domains, a  high percentage of 
which associate with the PML nuclear bodies. 
Discussion 
Here we report that infection by adenovirus causes a dras- 
tic redistribution of PML from spherical to fibrous-appear- 
ing nuclear structures, which, at the electron microscopic 
level, consist of a meshwork of filaments of approximately 
12  nm in  diameter.  A  distinct  component of the  normal 
PML nuclear bodies, the SP100  protein (Szostecki et al., 
1990; Xie et al., 1993), is also detected in the adenovirus- 
induced fibrous structures in a subset of infected cells. Al- 
though we cannot exclude that the disappearance of SP100 
staining could be due to a  dispersion of the protein, it is 
more likely that SP100 is also present in the fibers, but is 
more difficult to detect, perhaps because it becomes less 
accessible for antibody binding. This argues that adenovi- 
rus does not only affect the specific localization  of PML, 
but  rather  disorganizes  the  whole  macromolecular com- 
plex into  fibrillar structures.  A  modification of the PML 
nuclear domain staining pattern was also observed in Her- 
pes Simplex Virus (HSV)-infected cells (Maul et al., 1993). 
However, in this case, viral infection completely abolished 
the labeling by antibodies directed against components of 
these nuclear domains, suggesting a complete disaggrega- 
tion  of the  complexes. These findings  indicate  the  exist- 
ence of an intimate association between the modification 
of the PML nuclear bodies and events surrounding infec- 
tion by different types of DNA viruses. 
Using a series of adenovirus early region 4 (E4) mutant 
viruses  and  plasmid  vectors expressing  single  E4-ORFs, 
we demonstrate that the ORF3 product is responsible for 
the disorganization of the PML subnuclear structures.  In 
this context, it is noteworthy that both PML (Stuurman et 
al.,  1992)  and  the  ll-kD  protein  encoded  by  E4-ORF3 
(Sarnow et al., 1982) have been shown to be tightly associ- 
ated with the nuclear matrix, the structure and function of 
which is still poorly understood. The elucidation of the bi- 
ological properties of E4-ORF3 should contribute to our 
understanding of nuclear matrix function. The adenovirus 
E4 region is a  complex transcription unit that encodes at 
least seven distinct proteins (Freyer et al., 1984;  Virtanen 
et  al.,  1984)  and  specific  biological  activities  have  only 
been attributed to four of them. The ORF4 product is an 
activator  of  protein  phosphatase  2A  (Kleinberger  and 
Shenk,  1993).  The ORF6/7  hybrid protein activates tran- 
scription from the adenovirus E2 promoter by facilitating 
cooperative  DNA-binding  of  E2F-1/DP-1  heterodimers 
(Helin and Harlow, 1994;  Bandara et al., 1994  and refer- 
ences therein).  The ORF6 protein forms a  complex with 
the EIB 55K protein that inhibits cytoplasmic accumula- 
tion of host cell mRNA and facilitates transport of late vi- 
rus-encoded mRNAs (Cutt  et al.,  1987;  Bridge and Ket- 
ner,  1990).  In addition,  ORF 3 and 6 proteins have been 
shown to be jointly implicated in the regulation of alterna- 
tive splicing of viral mRNAs (Ohman et al.,  1993;  Nord- 
qvist et  al.,  1994)  and  viral DNA synthesis  (Huang  and 
Hearing, 1989; Bridge and Ketner, 1989).  These two prod- 
ucts have redundant activities during lytic infection, since 
expression of one of them is sufficient to substitute for the 
whole E4 region in establishing a wild type virus infection 
(Huang and Hearing, 1989; Bridge and Ketner, 1989). 
Our finding that the ORF3 protein is alone sufficient for 
causing the redistribution of PML implies that the reorga- 
nization  of the  associated nuclear  bodies is not essential 
for viral lytic infections since the ORF6 product can func- 
tionally  replace  ORF3  in  virus  production  without  con- 
comitant PML redistribution.  The  biological significance 
of the  ORF3-induced  reorganization  of the  PML bodies 
remains  unclear.  The  only data  reported  to  date  on  the 
functions  of ORFs 3  and  6  suggest that  they may be in- 
volved in RNA splicing, since ORF3 was shown to facili- 
tate exon inclusion and ORF6 exon skipping of major late 
mRNAs (Nordqvist et al., 1994).  In this respect, it is note- 
worthy that snRNPs have recently been shown to reorga- 
nize  upon  adenovirus  infection  (Puvion-Dutilleul  et  al., 
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sent active sites of mRNA processing, one might have ex- 
pected a colocalization of ORF6 with ORF3 in such struc- 
tures. In fact, the distribution  of ORF6 was found to be 
exclusively  nuclear  diffuse.  Moreover,  previous  experi- 
ments  on  non-infected  cells  have  failed  to  demonstrate 
any colocalization between the intact PML nuclear bodies 
and snRNP-containing organelles (Weis et al., 1994), nor 
do  we  show  here  any  correlation  between  the  ORF3- 
induced  fibers and  sites of RN,A splicing.  The PML nu- 
clear bodies may therefore represent active sites for an ad- 
ditional  ORF3  function, distinct  from its possible role in 
RNA splicing. 
Because the disruption  of the PML-associated nuclear 
structures  was  first  implicated  in  an  oncogenic  process 
(Weis et al., 1994; Dyck et al., 1994; Koken et al., 1994), we 
were  interested in examining the intracellular localization 
of the adenoviral E1.A oncoproteins. In addition to being 
diffusely distributed in the nucleoplasm, a significant por- 
tion of the E1A proteins concentrated in the PML nuclear 
structures.  Further,  the EI.A products were seen both in 
the abnormal, ORF3-induced  fibers resulting from infec- 
tion, as well as in the normal spherical bodies seen upon 
transfection of either the 12S or 13S E1.A cDN.As. The bi- 
ological significance for this concentration remains to be 
elucidated. The spatial proximity of E1.A and PML in sub- 
nuclear structures is unlikely to be the result of direct asso- 
ciation  since  both  co-immunoprecipitation  and  in  vitro 
binding studies failed to detect any specific interaction be- 
tween the  two proteins  (our unpublished  results).  Unex- 
pectedly, E1A does not accumulate in the otherwise intact 
nuclear  bodies  of 293  cells  (which  constitutively express 
El.A),  but rather exhibits an exclusively diffuse distribu- 
tion within the nucleoplasm. However, upon transfection 
of an  E1.A  expression  plasmid,  E1A  was  now  found  to 
concentrate into the PML structures (our unpublished ob- 
servations). It remains to be established whether the PML 
nuclear  bodies simply function  as storage organelles for 
the  overexpression-dependent  accumulation  of E1A,  or 
whether they represent subnuclear compartments for spe- 
cific EiA-associated biochemical processes. 
Distinct biological functions have been attributed to dis- 
crete amino acid sequences in adenovirus E1.A proteins. 
Identification of the region responsible for the concentra- 
tion of EIA in the  PML nuclear bodies might therefore 
provide clues as to the function of the whole macromolec- 
ular complex. `Analysis of the nuclear localization of mu- 
tant E1.A proteins revealed that the (D)LXCXE motif in 
the conserved region 2 (CR2) is critical for the association 
of E1A with the PML nuclear bodies. This motif, which is 
also present in other DNA tumor virus oncoproteins, in- 
cluding large T  antigehs from simian virus 40 (SV-40 LT) 
and polyomavirus as well as the human papillomavirus E7 
protein, has been shown to be essential for binding to pRB 
and  to  the  related  p107  and  p130  proteins  (reviewed in 
Moran,  1993,  and Bayley and Mymryk, 1994).  In El.A,  a 
single substitution within this motif, changing Cys-124 to 
Gly (pm 928), has been shown to abrogate both pRB bind- 
ing and E1A transforming ability. Since the pm928 muta- 
tion did not affect E1.A accumulation in the PML bodies, 
we suggest that the targeting of E1.A to these structures is 
dependent on a CR2 function distinct from its pRB bind- 
ing properties. In this regard, we failed to demonstrate any 
concentration  of the  endogenous pRB  in  the  PML sub- 
structures.  However,  when  overexpressed  together  with 
PML in transfected cells, pRB accumulated into large nu- 
clear aggregates which we did not investigate further (our 
unpublished observations). Finally, the SV-40 LT antigen 
was also shown to concentrate in discrete domains closely 
associated  with  those  containing  PML.  Taken  together, 
our results demonstrate that the nuclear matrix-associated 
PML  structures  represent  preferential  targets  for  small 
DNA  tumor  virus  oncoproteins.  Further  analysis  of the 
composition  and  function  of  the  PML  nuclear  bodies 
should  help  elucidate  the  biological  implications  of the 
present observations. 
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